MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,905,557 | -99.9% | 42,056 | -19.4% | 0.01% | -55.2% |
| Q3 2022 | $3,642,156,000 | +24.4% | 52,150 | +19.6% | 0.03% | +7.4% |
| Q2 2022 | $2,927,472,000 | -29.2% | 43,609 | -13.3% | 0.03% | -20.6% |
| Q1 2022 | $4,136,899,000 | +12.5% | 50,315 | +100.8% | 0.03% | +30.8% |
| Q4 2021 | $3,676,344,000 | +28.8% | 25,062 | +55.4% | 0.03% | +23.8% |
| Q3 2021 | $2,853,558,000 | +23.7% | 16,130 | +13.0% | 0.02% | +16.7% |
| Q2 2021 | $2,306,325,000 | +41.8% | 14,278 | +0.3% | 0.02% | -30.8% |
| Q2 2020 | $1,625,894,000 | +152997.4% | 14,241 | +3.0% | 0.03% | +62.5% |
| Q1 2020 | $1,062,000 | -62.4% | 13,820 | -37.0% | 0.02% | -27.3% |
| Q4 2019 | $2,827,000 | +334.3% | 21,940 | +162.4% | 0.02% | +266.7% |
| Q3 2019 | $651,000 | – | 8,362 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |